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1. ~troduction 
Brain membranes have specific sites for GABA 
binding in the absence of sodium. These sites are of 
high and low affinities [l-6]. The binding material 
containing the high affinity sites has been solubilized 
with either lysolecithins or detergent and partially 
purified [7,8]. A proteolipid has also been partially 
purified from rat brain which showed a site of low 
affinity when tested in an organic medium [6]. Since 
the availability of the pure receptor could help to 
solve problems about the presence of several GABA 
binding sites and their relation~ip to the membrane 
binding sites for agonists [9], benzodiazepines [lo], 
GABA-modulin [3], and any other ligand, we under- 
took the purification of the receptor. 
We report the isolation of a hydrophobic peptide 
that is chromatographically and electrophoretica~y 
homogeneous and that binds GABA specifically with 
high and low affinities in organic or aqueous medium. 
2. Materials and methods 
2.1. ~ri~catio~ of the re~~pto$-~~~e ~eptide 
Adult bovine brain was minced with 3 vol. cold 
acetone in a blender. The mixture was filtered and 
the cake extracted twice with acetone. The cake was 
then extracted 3 times with 2 vol. each of petroleum 
ether (b-p. SO-70°C) and filtered. The ether extracts 
were pooled and evaporated to dryness. The residue 
was suspended in 600 ml C/M (1: 2, v/v), 60 ml of 
1 M NaOH were added, incubated for 4 h at 4S’C and 
A bbreuiufions: GABA, r-aminobutyric acid; C, chloroform; 
M, methanol; TLC, thin-layer chromatography;ZC,,, concen- 
tration causing 50% ~hibition of specific [‘H]GABA binding 
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neutralized with acetic acid. To partition [l l], 6OOml 
C and 240 ml water were added, mixed and the upper 
phase discarded. The lower phase was washed twice 
with theoretical upper phase, and evaporated to dry- 
ness. The residue was suspended in 100 ml C/M/water 
(60:30:4.5, by vol.) and dialyzed in cellophane sacs 
against 10 X 3 vol. same mixture for 3 days. The out- 
side fluids were evaporated to dryness, suspended in 
100 ml C/M/water (60:30:4.5, by vol.) and passed 
through a DEAE-Sephadex column (2 X 40 cm, ace- 
tate form) equilibrated with the same solvent. The 
column was washed with 2 vol. solvent mixture and 
the non-retained material was evaporated to dryness. 
The residue was solubilized in 200 ml methanol at 
5S”C, cooled at 0°C and the cholesterol crystals were 
centrifuged off in the cold. This operation was repeated 
until no more cholesterol crystals were formed. The 
solution was evaporated to dryness, the residue dis- 
solved in C~M~water (60:30:4.5, by vol.) and passed 
through a column of silica gel H (3 X 30 cm) equili- 
brated with this solvent mixture. The column was 
eluted with 5 vol. same solvent collected into fractions 
of 5 ml each. The fractions with binding activity were 
pooled and evaporated to dryness. The residue was 
solubilized in C~M/water (25:50: 15, by vol.) and 
passed through a column of silica gel H (1.3 X 15 cm) 
equilibrated with the same solvent. Three volumes 
of this mixture were passed through the column and 
collected into fractions of 1 ml each. The fractions 
with binding activity were pooled, evaporated and 
subjected to TLC on washed silica gel H. The following 
developing mixtures were successively used: (A) 
C/M/15 Nammonia(60:30:4.5,byvol.);(B)C/M/gla- 
cial acetic acid (10:10:3, by vol.);(C) C/M/water 
(5:10:3, by vol.); and (D) C:M (2:1, v/v). A strip of 
each plate was cut out and stained with ni~ydrin, or 
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charred with sulphuric acid. The silica from the 
remainder plate fragment was scrapped off into frac- 
tions and eluted with C/M/water (60:30:4.5, by vol.). 
The eluates were evaporated to dryness and the 
material partitioned [ 111. The lower phases were 
washed twice with theoretical upper phase. 
2.2. Binding determinations 
2.2.1. In organic medium 
Material from -100 mg fresh tissue was dissolved 
in 0.6 ml C/M (2: 1, v/v/). [3H] GABA (New England 
Nuclear, 43 Ci/mmol) was added in 5 d water when 
the lowest concentrations of ligand (5-10 nM) were 
assayed. For higher concentrations of the ligand, 
10 nM [3H] GABA plus different amounts of non-radio- 
active GABA to reach final concentrations between 
20 nM and 50 mM of the total ligand, were added. 
After incubation at 22°C for 20 min, 1 ml water was 
added and the mixture vigorously shaken and centri- 
fuged. The upper phases were discarded, the lower 
phases were washed 3 times with 1 ml theoretical 
upper phase, evaporated to dryness in a vial and their 
radioactivities measured. 
2.2.2. In aqueous medium 
This method was used with the homogeneous 
receptor. Preparations in intermediate stages of purifi- 
cation contained too much lipid to allow the use of 
this method. The peptide (60 pg) was suspended by 
sonication (5 s) in 0.6 ml/l .6 mM Tris-HCl buffer 
@H 7.4). Radioactive and non-radioactive GABA 
were added as indicated above. The mixture was incu- 
bated at 22°C for 20 min and 1 ml C/M (2: 1, v/v) 
added. The lower phase was washed 3 times with 1 ml 
theoretical upper phase, evaporated to dryness and 
its radioactivity was measured. For procedures in 
organic and aqueous medium, controls for zero incu- 
bation time and incubations in the presence of 50 mM 
of non-radioactive GABAwere run to discount the non- 
displaced [3H] GABA binding. Determinations were 
done in triplicate. The average deviations were <I 0%. 
This partition method [ 1 I] was tested for the separa- 
tion of free and bound ligands. Results showed that 
<OS% of the original ligand remained free in the 
lower phase which in every case was discounted with 
the appropiate control. It was also tested for the dis- 
sociation of the bound-receptor ligand; after 3 wash- 
ings practically no more [ 3H] GABA passed to the 
upper phase. 
2.3. Electrophoresis 
This was performed on 0.1% sodium dodecyl sul- 
phate-10% polyacrylamide according to [ 121. Fixing, 
staining with Coomassie blue and destaining were car- 
ried out according to [ 131. 
Table 1 
Purification of the GABA receptor-like constituent of bovine brain 
Preparation pmol GABA bound/ 
g fresh brainb 
pmol GABA bound/ 
mg proteinC 
Total braina 8.55 0.071 
Ether extract 8.55 2.13 
Unsaponifiable 8.45 7.04 
Dialyzable 8.04 44.46 
Not retained by 
DEAE-Sephadex 7.93 88.11 
Methanol soluble 7.81 97.60 
Eluted from 
silica colums 4.47 112.00 
a The values corresponding to total brain were calculated from the values of the 
ether extract because this solvent extracted quantitatively the binding activity 
b The binding activity lost at each step of purification was found in the corre- 
sponding discarded fraction 
’ The protein was determined according to [ 141 except for the material at the 
material at the final step in which the protein was determined by the biuret 
method [ 151 
The incubation conditions for [ ‘H]GABA binding were as indicated in section 2.2, 
organic medium. Values shown were obtained in the presence of 20 nM [ 3H]GABA 
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3. Results and discussion 
The results of the different steps of purification 
(table 1) show that the peptide has solubility proper- 
ties of a proteolipid but at variance with most proteo- 
lipids so far described [ 161, the receptor is dialyzable 
and is not denaturated by being subjected to mild 
saponification or evaporation to dryness. The final 
recovery of binding capacity was 40-50% of that in 
the eth.er extract. The binding activity lost at each 
step of purification was found in the corresponding 
discarded fractions; the purification data did not sug- 
gest in any step the presence of activators or inhibitors 
in the ether starting preparation. Judging from the 
fold-purification this peptide constitutes <O.l% of 
the brain proteins. At several steps the material was 
partitioned [ 1 I] and washed to eliminate hydrophilic 
substances. The strongly hydrophobic property of the 
peptide made possible the use of the partition to 
eliminate free [3H] GABA without loss of binding 
material. In addition the receptor-GABA complex 
formed with high affinity was not readily dissociable 
in the chloroformic phase and the radioactivity 
remained practically constant after 3 washings. This 
property of the complex was also observed when 
higher GABA concentrations were used. This allowed 
the measurement of low af‘tinity, very dissociable, 
sites. The amount of GABA bound to the peptide/g 
total brain (8.55 pmol) was of the same order but 
somewhat less than the 20 pmol/g total brain reported 
with disrupted and washed membranes [17]. 
The homogeneity and the peptide nature of the 
receptor isolated by the method outlined were indi- 
Fig.1. Thin-layer chromatography of the peptide receptor 
(60 pg). Developing solvent mixtures, A-D, as indicated in 
section 2.1. The spots were exposed by charring with 50% 
sulphuric acid at 140°C. Specific [3H]GABA binding of the 
peptide in cpm X 10“‘. 
pept ide 
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Fig.2. SDS-polyacrylamide gel electrophoresis of the peptide 
receptor. Bottom: protein markers, ovoalbumin, 45 000 Mr; 
trypsinogen, 24 000 MI, and lysozyme, 14 000 Mr. Top: 
peptide receptor (1 LO gg). 
cated by the followings results: The material run on 
TLC with 4 different solvent mixtures showed a single 
band when charred with sulphuric acid (fig.1) or 
stained with ninhydrin (not shown). These bands 
coincided between themselves and with that having 
binding activity (fig.1). After gel electrophoresis and 
staining with Coomassie blue, the peptide also showed 
a single band with of Mr -11 000 (fig.2). Treatment 
with protease (Sigma Chemicals, type VI) caused a 
decrease of 90% of the specific GABA binding to the 
highest affinity site of the receptor peptide (table 2). 
The curve of the GABA binding to the peptide 
showed 4 dissociation constants. This was so whether 
the binding was carried out in organic or aqueous 
medium (fig.3). The Kd andB, values were calculated 
from Scatchard analysis of each independent satura- 
Table 2 
Effect of the protease on the specific [‘H]GABA binding 
to the highest affinity site of the receptor peptide 
Additionsa Specific bindingb 
Peptide (50 pg) 
Peptide (50 ug) 
+ protease (50 pg) 
Peptide (50 ug) 
+ protease (50 fig), zero time 





a The indicated additions were incubated in 0.2 ml 0.05 M 
Tris-acetate buffer (pH 7.1) for 10 hat 37°C. The diges- 
tion was stopped by adding 20 vol. C/M (2: 1, v/v) and 
partitioned. The lower phase was separated and evaporated 
to dryness 
b The residue obtained from the lower phase was tested for 
binding activity in organic medium (see section 2.2) with 
1.5 nM [3H]GABA 
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Fig.3. Saturation curves of the specific binding of [3H]GABA 
to homogeneous peptide (60 fig). The binding activity was 
measured as in section 2.2. Organic medium (o-o);aqueous 
medium (0-o). The experiments in both media were 
repeated twice with practically identical results. 
Fig.4. Scatchard plots of the four sites of specific [ 3H]GABA 
binding to homogeneous peptide, in aqueous medium. The 
data shown are those in fig.3. The regression line at each 
independent site drawn through the experimental points was 
computer-fitted. The correlation coefficients were, for site 
Kd, 0.97; Site. Kd, 0.94; Site Kd, 0.81; and site Kd 0.90. 
4 
tion curve using the points nearest to the maximal 
binding (fig.4). The values for Kd were 15 nM, 90 nM, 
112 nM and 0.66 mM. Those for B, were 1 X IO-‘, 
5 X 10 -4, 1 X 10m3 and 3 mol GABA/mol peptide. 
The amounts of GABA bound to each site were widely 
different, the 3 sites of high affinity amounting to 
-0.1% of the total binding activity of the peptide. 
A great difference of binding capacity between high 
and low affinity sites were also found in membranes 
[Sl. 
Further evidence on the possible identity between 
this peptide and the receptor were the characteristics 
of displacement of [3H]GABA from the high affinity 
site by muscimol (ZC50 3 nM), GABA (ZC,, 99 nM), 
and imidazoleacetate ((c,, 790 nM). The /Cso values 
found with the purified peptide are in the range of 
values reported by other authors with membranes 
or less purified materials. For (t) bicuculline we 
found an 1C5o value of >.500 /IM which supports the 
conclusion of those authors who indicate that binding 
sites for this antagonist and GABA might differ (see 
[9]). In addition, the specific [3H]GABA binding to 
the other 3 sites, measured at [3H]GABA concentra- 
tionsof6X 10-*,4X 10m7and4X 10AM,were 
inhibited by 80-8670 when muscimol was added at 
the same concentrations of GABA indicated for each 
site (not shown). 
Perhaps the most interesting finding so far obtained 
with the purified peptide is that it showed 4 binding 
sites whose Kd are similar to those described in mem- 
branes which are: 32 nM [l], 16 and 130 nM [2], 20 
and 110 nM [3], 21 nM [4] and 30 FM [6], There is 
fair coincidence between the values of these K, and 
those found for the peptide (see above). Whether the 
different binding sites are expressions of different 
molecules that purify in approximately the same 
proportions as they are in the membranes or of dif- 
ferences in conformation or aggregation of a single 
primary structure, the receptor appears to maintain 
in solution the same properties it has in membranes. 
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